2,3-dinor-thromboxane b2 and Cardiovascular Diseases
2,3-dinor-thromboxane b2 has been researched along with Cardiovascular Diseases in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bassi, A; Calapai, G; Caputi, AP; Gregg, E; Lowe, F; Mannucci, C; McEwan, M; Morandi, S; Nunziata, A; Puntoni, R; Russo, GA | 1 |
| Benthin, G; Granström, EF; Persson, L; Rångemark, C; Wennmalm, A; Winell, S | 1 |
| Daugherty, J; FitzGerald, GA; Healy, C | 1 |
Reviews
1 review(s) available for 2,3-dinor-thromboxane b2 and Cardiovascular Diseases
| Article | Year |
|---|---|
Thromboxane A2 biosynthesis in human disease.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Liver; Male; Prostaglandin Endoperoxides; Thromboxane A2; Thromboxane B2 | 1987 |
Other Studies
2 other study(ies) available for 2,3-dinor-thromboxane b2 and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiovascular biomarkers in groups of established smokers after a decade of smoking.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Disease Progression; Female; Hemoglobins; Humans; Leukocyte Count; Male; Risk Factors; Sex Factors; Smoking; Tars; Thromboxane B2; Thromboxanes; Young Adult | 2009 |
Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Age Factors; Cardiovascular Diseases; Female; Gas Chromatography-Mass Spectrometry; Humans; Middle Aged; Platelet Activation; Risk Factors; Smoking; Smoking Cessation; Thromboxane B2 | 1992 |